These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 6233249

  • 21. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R, Michéa-Hamzehpour M, Pechère JC.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [Abstract] [Full Text] [Related]

  • 22. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A.
    Arzneimittelforschung; 1983 Apr; 33(12):1623-7. PubMed ID: 6230083
    [Abstract] [Full Text] [Related]

  • 23. In vitro activity of ciprofloxacin (Bay o 9867).
    Fass RJ.
    Antimicrob Agents Chemother; 1983 Oct; 24(4):568-74. PubMed ID: 6228192
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of ciprofloxacin and norfloxacin against Gardnerella vaginalis.
    Machka K.
    Eur J Clin Microbiol; 1984 Aug; 3(4):374. PubMed ID: 6237906
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents.
    Gadebusch HH, Shungu DL, Weinberg E, Chung SK.
    Infection; 1982 Jan; 10(1):41-4. PubMed ID: 6461606
    [Abstract] [Full Text] [Related]

  • 26. In vitro evaluation of A-56619 and A-56620, two new quinolones.
    Barry AL, Thornsberry C, Jones RN.
    Antimicrob Agents Chemother; 1986 Jan; 29(1):40-3. PubMed ID: 2942099
    [Abstract] [Full Text] [Related]

  • 27. Comparative activity of the 4-quinolones.
    Phillips I, King A.
    Rev Infect Dis; 1988 Jan; 10 Suppl 1():S70-6. PubMed ID: 3279501
    [Abstract] [Full Text] [Related]

  • 28. Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Traub WH.
    Chemotherapy; 1985 Jan; 31(1):34-9. PubMed ID: 3156026
    [Abstract] [Full Text] [Related]

  • 29. [Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].
    Dabernat H, Delmas C, Lareng MB.
    Pathol Biol (Paris); 1985 May; 33(5):385-8. PubMed ID: 3162140
    [Abstract] [Full Text] [Related]

  • 30. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.
    Gay JD, DeYoung DR, Roberts GD.
    Antimicrob Agents Chemother; 1984 Jul; 26(1):94-6. PubMed ID: 6236748
    [Abstract] [Full Text] [Related]

  • 31. Activities of newer quinolones against Legionella group organisms.
    Greenwood D, Laverick A.
    Lancet; 1983 Jul 30; 2(8344):279-80. PubMed ID: 6135099
    [No Abstract] [Full Text] [Related]

  • 32. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
    Clarke AM, Zemcov SJ, Campbell ME.
    J Antimicrob Chemother; 1985 Jan 30; 15(1):39-44. PubMed ID: 3156112
    [Abstract] [Full Text] [Related]

  • 33. In vitro studies of S-25930 and S-25932, two new 4-quinolones.
    Piddock LJ, Andrews JM, Diver JM, Wise R.
    Eur J Clin Microbiol; 1986 Jun 30; 5(3):303-10. PubMed ID: 2943589
    [Abstract] [Full Text] [Related]

  • 34. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
    Joly-Guillou ML, Bergogne-Berezin E.
    Pathol Biol (Paris); 1985 May 30; 33(5):416-20. PubMed ID: 3162142
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.
    Seibert G, Limbert M, Klesel N.
    Eur J Clin Microbiol; 1983 Dec 30; 2(6):548-53. PubMed ID: 6230226
    [Abstract] [Full Text] [Related]

  • 36. Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
    Teoh-Chan CH, Cowlishaw A, Eley A, Slater G, Greenwood D.
    J Antimicrob Chemother; 1985 Jan 30; 15(1):45-52. PubMed ID: 3156113
    [Abstract] [Full Text] [Related]

  • 37. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
    Klietmann W, Focht J, Nösner K.
    Arzneimittelforschung; 1987 Jun 30; 37(6):661-6. PubMed ID: 2822054
    [Abstract] [Full Text] [Related]

  • 38. The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
    Ridgway GL, Mumtaz G, Gabriel FG, Oriel JD.
    Eur J Clin Microbiol; 1984 Aug 30; 3(4):344-6. PubMed ID: 6237903
    [Abstract] [Full Text] [Related]

  • 39. The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria.
    Corrado ML, Cherubin CE, Shulman M.
    J Antimicrob Chemother; 1983 Apr 30; 11(4):369-76. PubMed ID: 6222023
    [Abstract] [Full Text] [Related]

  • 40. In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.
    Heessen FW, Muytjens HL.
    Antimicrob Agents Chemother; 1984 Jan 30; 25(1):123-4. PubMed ID: 6230988
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.